LV.IL-2/B7.1-Transduced AML Blast Vaccine

A whole-cell cancer vaccine, containing human acute myeloid leukemic (AML) blasts that have been genetically engineered to express a B7.1/IIL-2 fusion protein encoded by a self-inactivating lentiviral vector (LV), with potential antineoplastic and immunomodulating activities. Upon administration, LV.IL-2/B7.1-transduced AML blast vaccine may stimulate a host cytotoxic T lymphocyte (CTL) response against AML cells. The single fusion protein encoded by the LV is postsynthetically cleaved to produce biologically active membrane-anchored B7.1 and secreted IL-2 in AML blasts; combined expression of IL-2 and the co-stimulatory molecule B7.1 by AML blasts may increase stimulation of both allogeneic and autologous cytotoxic T cells. (NCI Thesaurus)

YOU MAY ALSO LIKE

Luxol Fast Blue and Cresyl Violet Staining Method

A microscopy staining method that utilizes luxol fast blue, an alcohol soluble copper phthalocyanine dye, and cresyl violet, an organic compound that…

Luxembourg

A country in western Europe, between France, Belgium, and Germany.

Lux

A SI derived unit of illuminance equal to the direct illumination on a surface that is everywhere one meter from a uniform…

Luvox

A drug used to treat obsessive-compulsive disorder. It is a type of antidepressant agent and selective serotonin reuptake inhibitor (SSRI). Also called…

Lutropin

A hormone made in the pituitary gland. In females, it acts on the ovaries to make follicles release their eggs and to…

Lutetium texaphyrin

A substance that is being studied in the treatment of cancer using photodynamic therapy. It belongs to the family of drugs called…